![](/rp/kFAqShRrnkQMbH6NYLBYoJ3lq9s.png)
PDE4 inhibitor - Wikipedia
A phosphodiesterase-4 inhibitor, commonly referred to as a PDE4 inhibitor, is a drug used to block the degradative action of phosphodiesterase 4 (PDE4) on cyclic adenosine …
Phosphodiesterase Inhibitors: Types and Purpose - Cleveland Clinic
2022年6月8日 · PDE-4: This type is specific to your lungs, causing muscles in your airway (especially your bronchial tubes) to constrict and tense up. PDE-5: These are in the lungs, and …
List of Selective phosphodiesterase-4 inhibitors - Drugs.com
Selective phosphodiesterase-4 inhibitors are used in the treatment of severe Chronic Obstructive Pulmonary Disease (COPD) to reduce the risk of COPD exacerbations. They are not …
Popular Pde4 Inhibitors List, Drug Prices and Medication …
2024年10月29日 · See information about popular Pde4 Inhibitors, including the conditions they treat and alternatives available with or without insurance. Compare the cost of prescription and …
Phosphodiesterase Inhibitors - StatPearls - NCBI Bookshelf
2023年6月26日 · PDE-4 inhibitors decrease pro-inflammatory mediators and cause bronchodilation by inhibiting the degradation of cAMP. Theophylline is a non-specific PDE …
Phosphodiesterase-4 Enzyme Inhibitors: Drug Class, Uses, Side ... - RxList
Phosphodiesterase-4 enzyme (PDE-4) inhibitors are medications used to treat chronic obstructive pulmonary disease (COPD). Learn about how they work, usages, side effects, and a list of drugs.
How Do PDE4 Inhibitors (DMARDs) Work? - RxList
PDE4 inhibitors are prescribed to reduce inflammation and slow down disease progression in psoriasis, an inflammatory skin condition that can also lead to joint inflammation in many …
Phosphodiesterase 4 Inhibitors - DrugBank Online
Compounds that specifically inhibit PHOSPHODIESTERASE 4. A selective phosphodiesterase-4 inhibitor indicated to decrease the risk of exacerbations in patients with severe chronic …
An Overview of PDE4 Inhibitors in Clinical Trials: 2010 to Early 2022
Since the marketing of Roflumilast, three additional compounds have been marketed as PDE4-inhibitor drugs i.e., Crisaborole (by Pfizer) for atopic dermatitis , Apremilast (by Celgene) for …
PDE4 inhibitors: current status - PMC
Phosphodiesterase4 inhibitors are currently under development for the treatment of respiratory diseases including asthma and chronic obstructive pulmonary disease.
- 某些结果已被删除